普蕊斯(301257)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301257 普蕊斯

已收盘 01-13 15:00:00

{"stockData":{"symbol":"301257","market":"SZ","secType":"STK","nameCN":"普蕊斯","latestPrice":72.24,"timestamp":1768287813000,"preClose":60.2,"halted":0,"volume":2285032,"delay":0,"changeRate":0.2,"floatShares":75318900,"shares":79004800,"eps":1.5385,"marketStatus":"已收盘","change":12.04,"latestTime":"01-13 15:00:00","open":61.73,"high":72.24,"low":61.64,"amount":156000000,"amplitude":0.1761,"askPrice":0,"askSize":0,"bidPrice":72.24,"bidSize":12840,"shortable":0,"etf":0,"ttmEps":1.5385,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":60.2,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":66.22,"lowLimit":54.18,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":79004770,"isCdr":false,"pbRate":3.8,"roa":"--","peRate":46.954826,"roe":"7.2%","epsLYR":1.35,"committee":0,"marketValue":5707000000,"turnoverRate":0.0303,"status":0,"floatMarketCap":5441000000},"requestUrl":"/m/hq/s/301257","defaultTab":"news","newsList":[{"id":"2603573083","title":"异动快报：普蕊斯（301257）1月13日9点47分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2603573083","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603573083?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:50","pubTimestamp":1768269043,"startTime":"0","endTime":"0","summary":"证券之星1月13日盘中消息，9点47分普蕊斯触及涨停板。其所属行业医疗服务目前上涨。领涨股为泓博医药。该股为减肥药，肝炎概念，CAR-T疗法概念热股，当日减肥药概念上涨2.61%，肝炎概念概念上涨2.42%，CAR-T疗法概念上涨1.51%。1月12日的资金流向数据方面，主力资金净流入19.43万元，占总成交额0.21%，游资资金净流出10.72万元，占总成交额0.12%，散户资金净流出8.7万元，占总成交额0.1%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300009567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2603152365","title":"股市必读：普蕊斯(301257)股东户数0.68万户，较上期减少18.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603152365","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603152365?lang=zh_cn&edition=full","pubTime":"2026-01-13 03:19","pubTimestamp":1768245549,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，普蕊斯报收于60.2元，上涨0.1%，换手率2.01%，成交量1.51万手，成交额9047.07万元。股本股东变化股东户数变动近日普蕊斯披露，截至2025年12月31日公司股东户数为6759.0户，较11月28日减少1526.0户，减幅为18.42%。户均持股数量由上期的9536.0股增加至1.17万股，户均持股市值为60.83万元。董秘最新回复投资者： 你好 请问截止2026年1月9日公司股东人数多少？董秘： 尊敬的投资者您好，截至2025年12月31日收盘，公司股东总数为6,759户，感谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300003246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301257","BK0216"],"gpt_icon":0},{"id":"2602886516","title":"中邮证券：首次覆盖普蕊斯给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2602886516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602886516?lang=zh_cn&edition=full","pubTime":"2026-01-12 18:37","pubTimestamp":1768214231,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,陈灿近期对普蕊斯进行研究并发布了研究报告《Q3收入增速稳定，毛利率显著回暖》，首次覆盖普蕊斯给予买入评级。公司为国内SMO行业领导企业之一，考虑国内创新药投融资有望于26年进一步回暖，首次覆盖，给予“买入”评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200027319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301257"],"gpt_icon":0},{"id":"2601356141","title":"1月8日普蕊斯涨7.57%，天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601356141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601356141?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:41","pubTimestamp":1767858092,"startTime":"0","endTime":"0","summary":"证券之星消息，1月8日普蕊斯涨7.57%创60日新高，收盘报61.1元，换手率3.53%，成交量2.66万手，成交额1.58亿元。重仓普蕊斯的公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.63亿元，最新净值1.7894，较上一交易日上涨3.28%，近一年下跌6.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","159760","301257"],"gpt_icon":0},{"id":"2601356497","title":"普蕊斯涨7.57%，太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601356497","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601356497?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:41","pubTimestamp":1767858083,"startTime":"0","endTime":"0","summary":"今日普蕊斯涨7.57%，收盘报61.1元。2025年11月1日，太平洋研究员周豫,张崴发布了对普蕊斯的研报《Q3业绩超预期，需求有望持续好转》，该研报对普蕊斯给出“买入”评级。研报中预计2025年-2027年公司营收为8.28/9.50/11.07亿元，同比增长3.02%/14.72%/16.57%；归母净利为1.28/1.44/1.64亿元，对应PE为32/29/25倍，持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为67.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301257","601099"],"gpt_icon":0},{"id":"2601084818","title":"股市必读：普蕊斯（301257）1月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601084818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601084818?lang=zh_cn&edition=full","pubTime":"2026-01-07 04:45","pubTimestamp":1767732312,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，普蕊斯报收于54.0元，下跌2.26%，换手率1.91%，成交量1.44万手，成交额7740.12万元。董秘最新回复投资者： 你好 请问截止2025年12月31日 公司股东人数多少？谢谢董秘： 尊敬的投资者您好，截至2025年12月31日收盘，公司股东总数为6,759户，感谢您的关注！交易信息汇总资金流向1月6日主力资金净流入8.43万元；游资资金净流入25.17万元；散户资金净流出33.59万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700002048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2601046990","title":"普蕊斯：截至2025年12月31日股东总数为6,759户","url":"https://stock-news.laohu8.com/highlight/detail?id=2601046990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601046990?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:01","pubTimestamp":1767603662,"startTime":"0","endTime":"0","summary":"证券之星消息，普蕊斯(301257)01月05日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月31日的股东人数是多少？谢谢普蕊斯回复：尊敬的投资者您好，截至2025年12月31日收盘，公司股东总数为6,759户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500023484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2601500653","title":"1月5日普蕊斯涨6.17%，天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601500653","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601500653?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:47","pubTimestamp":1767599228,"startTime":"0","endTime":"0","summary":"证券之星消息，1月5日普蕊斯涨6.17%创60日新高，收盘报55.25元，换手率2.96%，成交量2.23万手，成交额1.22亿元。重仓普蕊斯的公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.63亿元，最新净值1.6401，较上一交易日下跌0.25%，近一年下跌6.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257","159760"],"gpt_icon":0},{"id":"2601006310","title":"普蕊斯涨6.17%，太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601006310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601006310?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:46","pubTimestamp":1767599218,"startTime":"0","endTime":"0","summary":"今日普蕊斯涨6.17%，收盘报55.25元。2025年11月1日，太平洋研究员周豫,张崴发布了对普蕊斯的研报《Q3业绩超预期，需求有望持续好转》，该研报对普蕊斯给出“买入”评级。研报中预计2025年-2027年公司营收为8.28/9.50/11.07亿元，同比增长3.02%/14.72%/16.57%；归母净利为1.28/1.44/1.64亿元，对应PE为32/29/25倍，持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为67.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","301257"],"gpt_icon":0},{"id":"2593437484","title":"股市必读：普蕊斯（301257）12月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593437484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593437484?lang=zh_cn&edition=full","pubTime":"2025-12-23 03:32","pubTimestamp":1766431934,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，普蕊斯报收于48.08元，上涨0.19%，换手率1.77%，成交量1.33万手，成交额6355.57万元。董秘最新回复投资者： 请问公司截止到12.20日的股东人数是多少?董秘： 尊敬的投资者您好，截至2025年11月28日收盘，公司股东总数为8,285户，感谢您的关注！交易信息汇总资金流向12月22日主力资金净流入115.81万元；游资资金净流入207.16万元；散户资金净流出322.97万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300002906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2592159767","title":"普蕊斯涨5.68%，太平洋一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2592159767","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592159767?lang=zh_cn&edition=full","pubTime":"2025-12-19 15:49","pubTimestamp":1766130587,"startTime":"0","endTime":"0","summary":"今日普蕊斯涨5.68%，收盘报47.99元。2025年11月1日，太平洋研究员周豫,张崴发布了对普蕊斯的研报《Q3业绩超预期，需求有望持续好转》，该研报对普蕊斯给出“买入”评级。研报中预计2025年-2027年公司营收为8.28/9.50/11.07亿元，同比增长3.02%/14.72%/16.57%；归母净利为1.28/1.44/1.64亿元，对应PE为32/29/25倍，持续给予“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为光大证券的王明瑞。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/19/20251219585709.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/19/20251219585709.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251219/31877319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["601099","301257"],"gpt_icon":0},{"id":"2592759159","title":"12月19日普蕊斯涨5.68%，天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592759159","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592759159?lang=zh_cn&edition=full","pubTime":"2025-12-19 15:49","pubTimestamp":1766130586,"startTime":"0","endTime":"0","summary":"证券之星消息，12月19日普蕊斯涨5.68%，收盘报47.99元，换手率3.2%，成交量2.41万手，成交额1.16亿元。重仓普蕊斯的公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共9家，其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.63亿元，最新净值1.6601，较上一交易日下跌0.54%，近一年下跌6.15%。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/19/20251219889784.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/19/20251219889784.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251219/31877318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LABU","XLV","159760","BK0216","BK4588","BK4581","XBI","BK4585","301257"],"gpt_icon":0},{"id":"2592191652","title":"普蕊斯（301257）披露公司股东减持计划实施完成公告，12月17日股价上涨1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592191652","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592191652?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:30","pubTimestamp":1765981850,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘，普蕊斯报收于45.2元，较前一交易日上涨1.12%，最新总市值为35.71亿元。普蕊斯（上海）医药科技开发股份有限公司近日发布公告，公司股东弘润盈科、石河子睿新及财务总监宋卫红通过集中竞价方式完成减持计划。弘润盈科减持6,500股，占总股本0.0082%，减持后持股为0；石河子睿新减持73,100股，占总股本0.0925%；宋卫红减持800股，占总股本0.0010%。减持后公司总股本未发生变化，仍为79,004,770股。本次减持与此前披露计划一致，未超出减持数量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700039986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301257","BK0216"],"gpt_icon":0},{"id":"2590167509","title":"普蕊斯：12月11日高管宋卫红减持股份合计700股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590167509","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590167509?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:03","pubTimestamp":1765544601,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月12日市场公开信息、上市公司公告及交易所披露数据整理，普蕊斯最新董监高及相关人员股份变动情况：2025年12月11日公司高管宋卫红共减持公司股份700.0股，占公司总股本为0.0009%。变动期间公司股价上涨3.71%，12月11日当日收盘报46.36元。普蕊斯近半年内的董监高及核心技术人员增减持详情如下：普蕊斯的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出320.49万，融资余额减少；融券净流入0.0，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200038402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301257","BK0216"],"gpt_icon":0},{"id":"2590598999","title":"普蕊斯：截至2025年11月28日股东总数为8,285户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590598999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590598999?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:42","pubTimestamp":1765438938,"startTime":"0","endTime":"0","summary":"证券之星消息，普蕊斯(301257)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止 2025 年 12 月 10 日股东人数是多少？谢谢！普蕊斯回复：尊敬的投资者您好，截至2025年11月28日收盘，公司股东总数为8,285户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100019738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2588044082","title":"普蕊斯：截至2025年11月28日股东总数为8,285户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588044082","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588044082?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:03","pubTimestamp":1764658997,"startTime":"0","endTime":"0","summary":"证券之星消息，普蕊斯(301257)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至11月30日的股东人数是多少？谢谢普蕊斯回复：尊敬的投资者您好，截至2025年11月28日收盘，公司股东总数为8,285户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200016906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301257","BK0216"],"gpt_icon":0},{"id":"2585686054","title":"普蕊斯(301257)10月31日股东户数0.86万户，较上期减少0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585686054","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585686054?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:53","pubTimestamp":1763978005,"startTime":"0","endTime":"0","summary":"证券之星消息，近日普蕊斯披露，截至2025年10月31日公司股东户数为8576.0户，较9月30日减少12.0户，减幅为0.14%。在医疗服务行业个股中，普蕊斯股东户数低于行业平均水平，截至10月31日，医疗服务行业平均股东户数为4.59万户。从股价来看，2025年9月30日至2025年10月31日，普蕊斯区间涨幅为9.41%，在此期间股东户数减少12.0户，减幅为0.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400022928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2585911142","title":"普蕊斯（301257）披露2025年前三季度权益分派实施公告，11月21日股价下跌2.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585911142","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585911142?lang=zh_cn&edition=full","pubTime":"2025-11-21 18:21","pubTimestamp":1763720487,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，普蕊斯报收于43.6元，较前一交易日下跌2.79%，最新总市值为34.45亿元。该股当日开盘44.17元，最高45.05元，最低42.42元，成交额达8842.52万元，换手率为2.69%。公司近日发布公告，宣布实施2025年前三季度权益分派。本次权益分派股权登记日为2025年11月27日，除权除息日为2025年11月28日。分配方案经第三届董事会第十六次会议审议通过，在2024年年度股东大会授权范围内，无需提交股东大会审议。自方案披露至实施期间，公司股本未发生变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100029131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2584187342","title":"普蕊斯（301257）披露股东减持股份预披露公告，11月20日股价上涨1.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584187342","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584187342?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:48","pubTimestamp":1763632098,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，普蕊斯报收于44.85元，较前一交易日上涨1.36%，最新总市值为35.43亿元。该股当日开盘44.36元，最高45.29元，最低43.3元，成交额达9205.41万元，换手率为2.75%。近日，普蕊斯（上海）医药科技开发股份有限公司发布关于公司股东减持股份预披露的公告。减持原因为基金结算及个人资金需求，减持方式为集中竞价交易，期间为公告发布之日起15个交易日后3个月内。相关股东承诺履行情况良好，减持符合监管规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000026903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2582549203","title":"普蕊斯(301257)10月31日股东户数0.86万户，较上期减少0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582549203","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582549203?lang=zh_cn&edition=full","pubTime":"2025-11-11 17:22","pubTimestamp":1762852935,"startTime":"0","endTime":"0","summary":"证券之星消息，近日普蕊斯披露，截至2025年10月31日公司股东户数为8576.0户，较9月30日减少12.0户，减幅为0.14%。在医疗服务行业个股中，普蕊斯股东户数低于行业平均水平，截至10月31日，医疗服务行业平均股东户数为4.6万户。从股价来看，2025年9月30日至2025年10月31日，普蕊斯区间涨幅为9.41%，在此期间股东户数减少12.0户，减幅为0.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100027814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768293725010,"stockEarnings":[{"period":"1week","weight":0.0896},{"period":"1month","weight":0.2746},{"period":"3month","weight":0.4328},{"period":"6month","weight":0.6655},{"period":"1year","weight":1.4354},{"period":"ytd","weight":0.1568}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"普蕊斯(上海)医药科技开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6759人(较上一季度减少18.42%)","perCapita":"11143股","listingDate":"2022-05-17","address":"上海市黄浦区思南路105号1号楼108室","registeredCapital":"7900万元","survey":"　　普蕊斯(上海)医药科技开发股份有限公司的主营业务是向国内外制药公司、医疗器械公司及部分健康相关产品的临床研究开发提供SMO服务。公司的主要产品是试验管理、GCP培训、GCP资质申请、中心推广、第三方稽查、技术体系搭建、机构管理、数据库服务、患者招募、FSP服务、数据建模/培训、第三方稽查、中心快速启动、患者招募、第三方稽查、中心可行性调研、协助患者入组随访。公司荣获国家知识产权局授予的两项发明专利：“一种不良事件等级判定方法、电子设备和存储介质”和“基于数据库的多中心协同执行项目质量监控系统”。这两项发明专利均为公司自主研发与设计取得。前者所涉及的技术显著提升了不良事件处理的效率与准确性，优化数据录入，是公司核心技术的重要延伸；后者所涉及的技术作为公司服务质量控制的核心，进一步增强项目质量监控的精确性与实时性，保障临床试验质量符合高标准高要求。凭借以上两项技术，公司为客户交付高质量的临床试验服务，彰显了公司技术领域的领先地位与持续创新的能力。","listedPrice":46.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普蕊斯(301257)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普蕊斯(301257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普蕊斯,301257,普蕊斯股票,普蕊斯股票老虎,普蕊斯股票老虎国际,普蕊斯行情,普蕊斯股票行情,普蕊斯股价,普蕊斯股市,普蕊斯股票价格,普蕊斯股票交易,普蕊斯股票购买,普蕊斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普蕊斯(301257)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普蕊斯(301257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}